Publications by authors named "Julie E Bauman"

60Publications

Gene targets of sulforaphane in head and neck squamous cell carcinoma.

Mol Med Rep 2019 Dec 23;20(6):5335-5344. Epub 2019 Oct 23.

Department of Otolaryngology‑Head and Neck Surgery, University of California at San Francisco, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mmr.2019.10766DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854598PMC
December 2019

Current Concepts in Chemotherapy for Head and Neck Cancer.

Oral Maxillofac Surg Clin North Am 2019 Feb;31(1):145-154

Medicine, Division of Hematology and Oncology, Translational Research, The University of Arizona Cancer Center, 1515 North Campbell Avenue, Tucson, AZ 85724, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10423699183008
Publisher Site
http://dx.doi.org/10.1016/j.coms.2018.09.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524526PMC
February 2019

When the Damage Is Done: Selecting Patients for Head and Neck Cancer Chemoprevention Trials.

Cancer Prev Res (Phila) 2017 09 18;10(9):489-490. Epub 2017 Aug 18.

Department of Internal Medicine, Division of Hematology/Oncology, University of Arizona, Tucson, Arizona.

View Article

Download full-text PDF

Source
http://cancerpreventionresearch.aacrjournals.org/lookup/doi/
Publisher Site
http://dx.doi.org/10.1158/1940-6207.CAPR-17-0197DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915371PMC
September 2017

E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.

J Clin Oncol 2017 Feb 28;35(5):490-497. Epub 2016 Dec 28.

Shanthi Marur and William H. Westra, Johns Hopkins University, Baltimore, MD; Shuli Li, Dana Farber Cancer Institute, Boston, MA; Anthony J. Cmelak, Jill Gilbert, and Barbara A. Murphy, Vanderbilt University, Nashville, TN; Maura L. Gillison and Weiqiang J. Zhao, Ohio State University, Columbus, OH; Robert L. Ferris and Julie E. Bauman, University of Pittsburgh, Pittsburgh, PA; Lynne I. Wagner, Wake Forest School of Medicine, Winston-Salem, NC; David R. Trevarthen, Colorado Cancer Research Program, Denver, CO; Jahagirdar Balkrishna, University of Minnesota, St Paul, MN; Nishant Agrawal, University of Chicago Medicine, Chicago, IL; A. Dimitrios Colevas, Stanford University, Stanford, CA; Christine H. Chung, Moffitt Cancer Center, Tampa, FL; and Barbara Burtness, Yale University, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.3300DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455313PMC
February 2017

Prevention of Carcinogen-Induced Oral Cancer by Sulforaphane.

Cancer Prev Res (Phila) 2016 Jul 23;9(7):547-57. Epub 2016 Jun 23.

Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-15-0290DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930727PMC
July 2016

Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer.

Int J Radiat Oncol Biol Phys 2016 07;95(3):973-980

Department of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; Department of Otolaryngology, Head and Neck Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.02.049DOI Listing
July 2016

The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations.

Oral Oncol 2016 May 28;56:84-92. Epub 2015 Dec 28.

Department of Internal Medicine, Division of Hematology/Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2015.11.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590227PMC
May 2016

Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts.

Mol Cancer Res 2016 Mar 18;14(3):278-86. Epub 2015 Dec 18.

Department of Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania. Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania. Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-15-0354DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794346PMC
March 2016

Oral Cancer Chemoprevention--The End of EPOC, the Beginning of an Epoch of Molecular Selection.

JAMA Oncol 2016 Feb;2(2):178-9

Department of Otolaryngology, University of California San Francisco, San Francisco.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.4637DOI Listing
February 2016

An enhanced role for palliative care in the multidisciplinary approach to high-risk head and neck cancer.

Cancer 2016 Feb 27;122(3):340-3. Epub 2015 Oct 27.

Department of Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29754DOI Listing
February 2016

Primary RET-mutated lung neuroendocrine carcinoma in MEN2B: response to RET-targeted therapy.

Endocr Relat Cancer 2015 Oct 18;22(5):L19-22. Epub 2015 Aug 18.

Division of Hematology/Oncology, Department of Internal Medicine, University of Pittsburgh Cancer Institute5150 Centre Avenue, 5th Floor, Pittsburgh, Pennsylvania, 15232USADivision of Anatomic Pathology, Department of Pathology, University of Pittsburgh Medical CenterPittsburgh, PennsylvaniaUSADivision of Endocrinology and Metabolism, Department of Internal Medicine, University of Pittsburgh Medical CenterPittsburgh, PennsylvaniaUSADivision of Molecular Genomic Pathology, Department of Pathology, University of Pittsburgh Medical CenterPittsburgh, PennsylvaniaUSA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-15-0307DOI Listing
October 2015

Persistent Salivary Human Papillomavirus DNA as a Surveillance Biomarker: Not Just Spitting in the Wind.

JAMA Oncol 2015 Oct;1(7):915-7

Division of Head and Neck Surgery, Department of Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.2606DOI Listing
October 2015

Cancer of the oropharynx.

Surg Oncol Clin N Am 2015 Jul 15;24(3):509-20. Epub 2015 Apr 15.

Department of Radiation Oncology, University of Pittsburgh Cancer Institute, 5150 Centre Avenue, Pittsburgh, PA 15232, USA; Department of Otolaryngology/Head and Neck Surgery, University of Pittsburgh Eye and Ear Institute, Suite 500, 200 Lothrop Street, Pittsburgh, PA 15213, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10553207150003
Publisher Site
http://dx.doi.org/10.1016/j.soc.2015.03.014DOI Listing
July 2015

Chemoprevention targets for tobacco-related head and neck cancer: past lessons and future directions.

Oral Oncol 2015 Jun 11;51(6):557-64. Epub 2015 Apr 11.

Department of Medicine, University of Pittsburgh, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2015.02.101DOI Listing
June 2015

Molecular characterization of apocrine salivary duct carcinoma.

Am J Surg Pathol 2015 Jun;39(6):744-52

Departments of *Pathology §Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA †Department of Pathology, Southern California Permanente Medical Group, Woodland Hills, CA ‡Department of Pathology, University Health Network, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000410DOI Listing
June 2015

A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck.

Int J Radiat Oncol Biol Phys 2015 Mar 30;91(3):480-8. Epub 2015 Jan 30.

Department of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; Department of Otolaryngology, Head and Neck Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2014.11.023DOI Listing
March 2015

CHK it out! Blocking WEE kinase routs TP53 mutant cancer.

Clin Cancer Res 2014 Aug;20(16):4173-5

Department of Oncology, Johns Hopkins University, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-0720DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860818PMC
August 2014

Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma.

Histopathology 2014 Dec 30;65(6):854-60. Epub 2014 Oct 30.

Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/his.12454
Publisher Site
http://dx.doi.org/10.1111/his.12454DOI Listing
December 2014

Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer.

Clin Cancer Res 2014 Jun 11;20(12):3289-98. Epub 2014 Apr 11.

Authors' Affiliations: Division of Head and Neck Surgery, Department of Otolaryngology, Oregon Health and Science University, Portland, Oregon; Division of Hematology/Oncology, Department of Internal Medicine; Department of Pharmacology and Chemical Biology;Biostatistics Facility, University of Pittsburgh, University of Pittsburgh Cancer Institute; Departments of Otolaryngology and Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas; Women's Health Integrated Research Center, Gynecologic Cancer Center of Excellence, Annandale, Virginia; Division of Hematology/Oncology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; and Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-3360DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104657PMC
June 2014

Human papillomavirus-associated adenocarcinoma of the base of tongue: potentially actionable genetic changes.

Head Neck Pathol 2014 Jun 21;8(2):151-6. Epub 2013 Nov 21.

Department of Pathology, University of Pittsburgh Medical Center, 200 Lothrop St, Pittsburgh, PA, 15213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12105-013-0508-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022938PMC
June 2014

Integrating novel therapeutic monoclonal antibodies into the management of head and neck cancer.

Cancer 2014 Mar 12;120(5):624-32. Epub 2013 Nov 12.

Department of Internal Medicine (Division of Hematology/Oncology), University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28380DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095869PMC
March 2014

Upregulation of the ATR-CHEK1 pathway in oral squamous cell carcinomas.

Genes Chromosomes Cancer 2014 Jan 21;53(1):25-37. Epub 2013 Oct 21.

Department of Internal Medicine, Division of Hematology-Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/gcc.22115
Publisher Site
http://dx.doi.org/10.1002/gcc.22115DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520977PMC
January 2014

Promising systemic immunotherapies in head and neck squamous cell carcinoma.

Oral Oncol 2013 Dec 11;49(12):1089-96. Epub 2013 Oct 11.

Department of Otolaryngology, University of Pittsburgh Eye and Ear Institute, 203 Lothrop Street, Pittsburgh, PA 15213, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2013.09.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861147PMC
December 2013

Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition.

Lancet Oncol 2013 Jul;14(8):e302-9

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(13)70085-8DOI Listing
July 2013

Comment on "epidermal growth factor receptor is essential for toll-like receptor 3 signaling".

Sci Signal 2012 Dec 11;5(254):lc5. Epub 2012 Dec 11.

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scisignal.2003734DOI Listing
December 2012

A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer.

BMC Cancer 2012 Oct 3;12:449. Epub 2012 Oct 3.

Department of Internal Medicine, Division of Hematology/Oncology and Biostatistics, University of New Mexico Cancer Center, Albuquerque, New Mexico, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-12-449DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517479PMC
October 2012

New promising molecular targets in head and neck squamous cell carcinoma.

Curr Opin Oncol 2012 May;24(3):235-42

Division of Hematology/Oncology, Department of Internal Medicine, University of New Mexico Cancer Center, Albuquerque, New Mexico, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e3283517920DOI Listing
May 2012

Relationship of protein and calorie intake to the severity of oral mucositis in patients with head and neck cancer receiving radiation therapy.

Head Neck 2012 May 20;34(5):655-62. Epub 2011 Jun 20.

Department of Internal Medicine, University of New Mexico Cancer Center, Albuquerque, New Mexico, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.21795DOI Listing
May 2012

Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.

Ann Thorac Surg 2008 Nov;86(5):1632-8; discussion 1638-9

Department of Medical Oncology, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2008.07.042DOI Listing
November 2008

Antagonism of platelet-derived growth factor receptor in non small cell lung cancer: rationale and investigations.

Clin Cancer Res 2007 Aug;13(15 Pt 2):s4632-6

University of Washington, Seattle Cancer Care Alliance, Seattle, Washington 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-0212DOI Listing
August 2007

Treatment of recurrent squamous cell carcinoma of the skin with cetuximab.

Arch Dermatol 2007 Jul;143(7):889-92

Division of Medical Oncology, University of Washington, Seattle Cancer Care Alliance, 825 Eastlake Ave E, G4-830, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archderm.143.7.889DOI Listing
July 2007